Tools Firm Illumina Considers Roche's Unsolicited $5.7B Bid
BioWorld Today Contributing Writer
The board of directors for Illumina Inc. is mulling over an unsolicited acquisition offer by Roche AG, of Basel, Switzerland, to purchase all outstanding shares in the San Diego-based genomics tools giant for $5.7 billion, or $44.50 per share in cash.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST